IL15 and neoplasm: Moreover, elimination of MDSCs with PD-L1-directed CAR-NK cells was a highly effective therapy in a MOC1 murine tumor model when combined with an anti-PD-1 antibody and the IL-15 super-agonist N-803 [47].